4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,372 | 72,488 | 60,241 | 48,555 | 77,159 |
| Marketable Securities | 290,962 | 318,404 | 342,414 | 256,508 | 216,066 |
| Receivables | 4,611 | N/A | N/A | N/A | N/A |
| TOTAL | $382,957 | $405,364 | $413,134 | $312,377 | $303,287 |
| Non-Current Assets | |||||
| PPE Net | 12,379 | 13,587 | 14,867 | 16,153 | 17,505 |
| Investments And Advances | 69,295 | 66,739 | 111,379 | 67,165 | 123,806 |
| Other Non-Current Assets | 27,984 | 27,215 | 27,331 | 28,287 | 29,039 |
| TOTAL | $109,658 | $107,541 | $153,577 | $111,605 | $170,350 |
| Total Assets | $492,615 | $512,905 | $566,711 | $423,982 | $473,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,522 | 14,692 | 11,159 | 6,863 | 8,700 |
| Accrued Expenses | 25,431 | 22,866 | 26,874 | 24,189 | 19,190 |
| TOTAL | $47,673 | $43,404 | $43,985 | $37,107 | $34,677 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,587 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 4,346 | 360 | 360 | 360 | 1,066 |
| Other Non-Current Liabilities | 14,741 | 15,540 | 16,317 | 17,057 | 17,851 |
| TOTAL | $37,283 | $17,665 | $17,062 | $17,892 | $18,070 |
| Total Liabilities | $84,956 | $61,069 | $61,047 | $54,999 | $52,747 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,244 | 52,276 | 51,051 | 57,135 | 46,702 |
| Common Shares | 6 | 5 | 6 | 5 | 5 |
| Retained earnings | -858,000 | -785,064 | -716,304 | -735,701 | -678,825 |
| Other shareholders' equity | -446 | -180 | 727 | 671 | 337 |
| TOTAL | $407,659 | $451,836 | $505,664 | $368,983 | $420,890 |
| Total Liabilities And Equity | $492,615 | $512,905 | $566,711 | $423,982 | $473,637 |